Rennova Health 10Q 2010 Q4 Quarterly report

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

	(Mark One)

	þ	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
		OF THE SECURITIES EXCHANGE ACT OF 1934

		For the quarterly period ended December 31, 2010

		or

	o	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
		OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 0-26824

TEGAL CORPORATION

(Exact Name of Registrant as Specified in Its Charter)

Delaware	68-0370244
(State or OtherJurisdiction of	(I.R.S. Employer Identification No.)
Incorporation or Organization)

2201 South McDowell Blvd.

Petaluma, California 94954

(Address of Principal Executive Offices)

Telephone Number (707) 763-5600

(Registrant’s Telephone Number, Including Area Code)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file reports) and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Sec.232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer“, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer o		Accelerated Filer o
Non-Accelerated Filer o (Do not check if a smaller reporting company)		Smaller reporting company þ

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes oNo þ

As of February 11, 2011, there were 8,444,714 of the Registrant’s common stock outstanding.

TEGAL CORPORATION AND SUBSIDIARIES

INDEX

		Page
	PART I. FINANCIAL INFORMATION

Item 1.	Condensed Consolidated Financial Statements (Unaudited)
	Condensed Consolidated Balance Sheets as of December 31, 2010 and March 31, 2010	3
	Condensed Consolidated Statements of Operations for the three and nine months ended December 31, 2010 and December 31, 2009	4
	Condensed Consolidated Statements of Cash Flows for the nine months ended December 31, 2010 and December 31, 2009	5
	Notes to Condensed Consolidated Financial Statements	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	15
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	23
Item 4.	Controls and Procedures	23

	PART II. OTHER INFORMATION

Item 1A.	Risk Factors	24
Item 6.	Exhibits	24
Signatures		25

PART I — FINANCIAL INFORMATION

Item 1. Condensed Consolidated Financial Statements

TEGAL CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except share data)

See accompanying notes to condensed consolidated financial statements.

	December 31,			March 31,
	2010			2010
ASSETS
Current assets:
Cash and cash equivalents	$	7,890		$	7,298
Accounts receivable, net of allowances for sales returns and doubtful accounts of $181 and $324 at December 31, 2010 and March 31, 2010, respectively.		1,571			3,116
Notes receivable		1,026			1,347
Inventories, net		1,196			1,221
Prepaid expenses and other current assets		134			1,243
Total current assets		11,817			14,225
Property and equipment, net		145			308
Intangible assets, net		1,062			1,230
Other assets		6			540
Total assets	$	13,030		$	16,303
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	493		$	1,520
Accrued product warranty		336			374
Common stock warrant liability		24			363
Deferred revenue		86			242
Accrued expenses and other current liabilities		2,293			1,867
Total current liabilities		3,232			4,366

Commitments and contingencies (Item 2)
Stockholders’ equity:
Preferred stock; $0.01 par value; 5,000,000 shares authorized; none issued and outstanding		-			-
Common stock; $0.01 par value; 50,000,000 shares authorized; 8,443,714 and 8,438,115 shares issued and outstanding at December 31, 2010 and March 31, 2010, respectively.		84			84
Additional paid-in capital		128,605			128,290
Accumulated other comprehensive loss		(178	)		(149	)
Accumulated deficit		(118,713	)		(116,288	)
Total stockholders’ equity		9,798			11,937
Total liabilities and stockholders’ equity	$	13,030		$	16,303

TEGAL CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except per share data)

	Three Months Ended						Nine Months Ended
	December 31,						December 31,
	2010			2009			2010			2009

Revenue	$	1,345		$	5,072			4,847		$	9,272
Inventory Provision		-			7,828			-			7,828
Cost of revenue		420			2,780			2,922			6,039
Gross profit/(loss)		925			(5,536	)		1,925			(4,595	)
Operating expenses:
Research and development expenses		733			1,503			2,298			3,913
Sales and marketing expenses		210			539			518			1,914
General and administrative expenses		554			957			2,631			2,930
Total operating expenses		1,497			2,999			5,447			8,757
Operating loss		(572	)		(8,535	)		(3,522	)		(13,352	)
Other income (expense), net		480			(244	)		1,103			227
Loss before income tax benefit		(92	)		(8,779	)		(2,419	)		(13,125	)
Income tax expense (benefit)		—			—			7			(50	)
Net loss	$	(92	)	$	(8,779	)	$	(2,426	)	$	(13,075	)

Net loss per share:
Basic	$	(0.01	)	$	(1.04	)	$	(0.29	)	$	(1.55	)
Diluted	$	(0.01	)	$	(1.04	)	$	(0.29	)	$	(1.55	)
Weighted average shares used in per share computation:
Basic		8,442			8,425			8,439			8,418
Diluted		8,442			8,425			8,439			8,418

See accompanying notes to condensed consolidated financial statements.

TEGAL CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

	Nine Months Ended December 31,
	2010			2009
Cash flows from operating activities:
Net loss	$	(2,426	)	$	(13,075	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization		553			1,075
Stock compensation expense		313			513
Stock issued under stock purchase plan		1			9
Fair value adjustment of common stock warrants		(339	)		(4	)
Decrease provision for doubtful accounts and sales returns allowances		(144	)		(43	)

Loss on disposal of property and equipment		185			61
Changes in operating assets and liabilities:
Accounts receivables and other receivables		1,794			(1,569	)
Inventories, net		25			8,602
Prepaid expenses and other assets		1,143			49
Accounts payable		(1,025	)		746
Accrued expenses and other current liabilities		427			(34	)
Accrued product warranty		(37	)		(301	)
Deferred revenue		(156	)		144
Net cash provided by (used in) operating activities		314			(3,827	)
Cash flows from investing activities:
Purchases of property and equipment		(406	)		(798	)
Net cash received on asset disposition		750			-
Net cash provided by (used in) investing activities		344			(798	)
Effect of exchange rates on cash and cash equivalents		(66	)		(34	)
Net increase (decrease) in cash and cash equivalents		592			(4,659	)
Cash and cash equivalents at beginning of period		7,298			12,491
Cash and cash equivalents at end of period	$	7,890		$	7,832

Supplemental disclosure of non-cash financing activities:
Reclassification of common stock warrant liability upon adoption of EITF 07-05 (Topic 815)	$	-		$	848

See accompanying notes to condensed consolidated financial statements.

TEGAL CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(All amounts in thousands, except per share data)

1. Basis of Presentation:

In the opinion of management, the unaudited condensed consolidated interim financial statements have been prepared on the same basis as the March 31, 2010 audited consolidated financial statements and include all adjustments, consisting only of normal recurring adjustments, necessary to fairly state the information set forth herein. The statements have been prepared in accordance with the regulations of the Securities and Exchange Commission (“SEC“), but omit certain information and footnote disclosures necessary to present the statements in accordance with generally accepted accounting principles (“GAAP“). These interim financial statements should be read in conjunction with the audited consolidated financial statements and footnotes included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2010. The results of operations for the three and nine months ended December 31, 2010 are not necessarily indicative of results to be expected for the entire year.

Our consolidated financial statements contemplate the realization of assets and the satisfaction of liabilities in the normal course of business for the foreseeable future. We incurred net losses of ($2,426) and ($13,075) for the nine months ended December 31, 2010 and 2009, respectively. We incurred net losses of ($92) and ($8,779) for the three months ended December 31, 2010 and 2009, respectively. We generated (used) cash flows from operations of $314 and ($3,827) for the nine months ended December 31, 2010 and 2009, respectively. We believe that our existing balances of cash and cash equivalents, combined with continued cost containment, will be adequate to fund operations through fiscal year 2011. While our cash balance temporarily improved in the three months ended December 31, 2010, our previously declining cash balance was a key support of the Company’s ongoing disclosure regarding its ability to continue as a going concern. Our business is dependent upon the sales of DRIE capital equipment, and projected sales may not materialize and unforeseen costs may be incurred. If the projected sales do not materialize, we will need to reduce expenses further and/or raise additional capital which may include capital raises through the issuance of debt or equity securities. If additional funds are raised through the issuance of preferred stock or debt, these securities could have rights, privileges or preferences senior to those of our common stock, and debt covenants could impose restrictions on our operations. Moreover, such financing may not be available to us on acceptable terms, if at all. Failure to raise any needed funds would materially adversely affect us. It is not possible to predict when our business and results of operations will improve. Therefore, the realization of assets and discharge of liabilities are each subject to significant uncertainty. Accordingly, substantial doubt exists as to whether we will be able to continue as a going concern. If the going concern basis is not appropriate in future filings, adjustments will be necessary to the carrying amounts and/or classification of assets and liabilities in our consolidated financial statements included in such filings. We indicated this concern in our Annual Report on Form 10-K for fiscal year ended March 31, 2010, which was also reflected in the audit opinion at that time.

In consideration of these circumstances, we are evaluating strategic alternatives for the Company, which may include a merger with or into another company, a sale of all or substantially all of our assets, the sale of our DRIE and other assets, and the liquidation or dissolution of the Company, including through a bankruptcy proceeding. The condensed consolidated financial statements include an adjustment to the value of the DRIE related assets to reflect the value of expected realizable market values that might result from the outcome of this uncertainty. See Note 6 – Asset Acquisitions and Sales.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash investments and accounts receivable. Substantially all of the Company’s liquid investments are invested in money market funds. The Company’s accounts receivable are derived primarily from sales to customers located in the United States, Europe and Asia. The Company performs ongoing credit evaluations of its customers and generally requires no collateral. The Company maintains reserves for potential credit losses. Write-offs during the periods presented have been insignificant.

As of December 31, 2010, two customers accounted for approximately 73% of the accounts receivable balance. As of December 31, 2009, three customers accounted for approximately 49% of the accounts receivable balance.

For the quarter ended December 31, 2010, Ulsan National Institute of Science and Technology and STMicroelectronics SA accounted for 71% and 10%, respectively, of total revenue. For the nine months ended December 31, 2010, a leading precision timing device manufacturer, Ulsan National Institute of Science and Technology, STMicroelectronics SA, and Uppsala University accounted for 28%, 20%, 18% and 17%, respectively, of total revenue. For the quarter ended December 31, 2009, IHP GmbH, Northrup Grumman Financial Service Center, Maluri Equipment Sdn. Bhd, and Canon Marketing Japan Inc accounted for 24%, 17%, 17%, and 15%, respectively, of total revenue. For the nine months ended December 31, 2009, PerkinElmer and the IHP Gmbh each accounted for 13% of total revenue.

The Company’s Note Receivable at December 31, 2010 consisted of the outstanding payments owed by OEM Group in connection with the sale of legacy etch and PVD assets completed in March 2010. See Note 6 – Assets Acquisitions and Sales.

Derivative Instruments

In June 2008, the Financial Accounting Standards Board (“FASB“) ratified the EITF consensus on EITF Issue No. 07-05, Determining Whether an Instrument (or Embedded Feature) Is Indexed to an Entity's Own Stock (“EITF Issue 07-05”) (Topic 815) which applies to the determination of whether any freestanding financial instruments or embedded features that have the characteristics of a derivative, as defined by SFAS No. 133 (Topic 815), Accounting for Derivative Instruments and Hedging Activities, and to any freestanding financial instruments are potentially indexed to an entity’s own common stock. EITF Issue No. 07-05 (Topic 815) became effective for fiscal years beginning after December 15, 2008. The Company adopted EITF 07-05 (Topic 815) as of April 1, 2009. As a result, warrants to purchase 1,427,272 shares of our common stock previously treated as equity pursuant to the derivative treatment exemption were no longer afforded equity treatment. The warrants had exercise prices ranging from $6.00-$99.00 and expire between February 2010 and September 2013. As such, effective April 1, 2009, the Company reclassified the fair value of these warrants, which had exercise price reset features, from equity to liability status as if these warrants were treated as a derivative liability since their date of issue between February 2000 and January 2006. On April 1, 2009, the Company reclassified $346 from additional paid-in capital, as a cumulative effect adjustment, to beginning accumulated deficit, and $502 to common stock warrant liability to recognize the fair value of such warrants on such date. As of March 31, 2010, the fair value of the warrants was estimated using the Black-Scholes pricing model with the following weighted average assumptions, risk-free interest rate of 2.55%, expected life of 1.06 years, an expected volatility factor of 74.2% and a dividend yield of 0.0%. At December 31, 2010, the fair of the warrants was $24. It was calculated using the Black-Scholes pricing model with the following weighted average assumptions, risk-free interest rate of 2.01%, expected life of 1.35 years, an expected volatility factor of 76.8%, and a dividend yield of 0.0%. The Company recorded a non-cash gain related to the warrants of $3 in the quarter ended December 31, 2010 and a non-cash gain of $53 in the quarter ended December 31, 2009.

Intangible Assets

Intangible assets include patents and trademarks that are amortized on a straight-line basis over periods ranging from 5 years to 7 years. The Company performs an ongoing review of its identified intangible assets to determine if facts and circumstances exist that indicate the useful life is shorter than originally estimated or the carrying amount may not be recoverable. If such facts and circumstances exist, the Company assesses the recoverability of identified intangible assets by comparing the projected undiscounted net cash flow associated with the related asset or group of assets over their remaining lives against their respective carrying amounts. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets.

Impairment of Long-Lived Assets

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable, as well as at fiscal year end. If undiscounted expected future cash flows are less than the carrying value of the assets, an impairment loss is recognized based on the excess of the carrying amount over the fair value of the assets. During the quarter ended December 31, 2010, we reviewed our long-lived assets for indicators of impairment in accordance with SFAS No. 144, (Topic 360). No impairment charges were recorded for intangible assets for the nine months ended December 31, 2010. For the fiscal year ended March 31, 2010, the Company recorded a $1,064 impairment charge for intangible assets and a $1,558 impairment charge for its fixed assets.

Stock-Based Compensation

We have adopted several stock plans that provide for issuance of equity instruments to our employees and non-employee directors. Our plans include incentive and non-statutory stock options and restricted stock awards. These equity awards generally vest ratably over a four-year period on the anniversary date of the grant, and stock options expire ten years after the grant date. Certain restricted stock awards may vest on the achievement of specific performance targets. We also have an Employee Stock Purchase Plan (“ESPP”) that allows qualified employees to purchase Tegal shares at 85% of the fair market value on specified dates.

Total stock-based compensation expense related to stock options and restricted stock units (“RSUs”) for the three months ended December 31, 2010 and 2009 was $56 and $201, respectively. Total stock-based compensation expense related to stock options and RSUs for the nine months ended December 31, 2010 and 2009 was $313 and $513, respectively. The total compensation expense related to non-vested stock options and RSUs not yet recognized is $532

The Company used the following valuation assumptions to estimate the fair value of options granted for the three month periods ended December 31, 2010 and 2009, respectively:

STOCK OPTIONS:	2010			2009
Expected life (years)		6.0			6.0
Volatility		74.3	%		89.1	%
Risk-free interest rate		1.51	%		2.15	%
Dividend yield		0	%		0	%

ESPP awards were valued using the Black-Scholes model with expected volatility calculated using a six-month historical volatility.

ESPP:	2010			2009
Expected life (years)		0.5			0.5
Volatility		86.1	%		75.1	%
Risk-free interest rate		0.12	%		0.06	%
Dividend yield		0	%		0	%

Valuation and Other Assumptions for Stock Options

Valuation and Amortization Method. We estimate the fair value of stock options granted using the Black-Scholes option valuation model. We estimate the fair value using a single option approach and amortize the fair value on a straight-line basis for options expected to vest. All options are amortized over the requisite service periods of the awards, which are generally the vesting periods.

Expected Term. The expected term of options granted represents the period of time that the options are expected to be outstanding. We estimate the expected term of options granted based on our historical experience of exercises including post-vesting exercises and termination.

Expected Volatility. We estimate the volatility of our stock options at the date of grant using historical volatilities. Historical volatilities are calculated based on the historical prices of our common stock over a period at least equal to the expected term of our option grants.

Risk-Free Interest Rate. We base the risk-free interest rate used in the Black-Scholes option valuation model on the implied yield in effect at the time of option grant on U.S. Treasury zero-coupon issues with remaining terms equivalent to the expected term of our option grants.

Dividends. We have never paid any cash dividends on common stock and we do not anticipate paying any cash dividends in the foreseeable future.

Forfeitures. We use historical data to estimate pre-vesting option forfeitures. We record stock-based compensation expense only for those awards that are expected to vest.

The Company does not use multiple share-based payment arrangements.

During the three months ended December 31, 2010, 565,181 stock option awards were granted.

Stock Options & Warrants

A summary of stock option and warrant activity during the quarter ended December 31, 2010 is as follows:

						Weighted
				Weighted		Average
				Average		Remaining		Aggregate
				Exercise		Contractual		Intrinsic
	Shares			Price		Term (in Years)		Value
Beginning outstanding		933,125		$	4.56
Granted
Price = market value		—			—
Total		—			—
Exercised		—			0.00
Cancelled
Forfeited		(20,010	)		2.96
Expired		(15,524	)		2.70
Total		(35,534	)		2.84

Ending outstanding		897,591		$	4.63		5.31	$	—
Ending vested and expected to vest		880,700		$	4.67		5.26	$	—
Ending exercisable		719,423		$	5.08		4.73	$	—

The aggregate intrinsic value of stock options and warrants outstanding at December 31, 2010 is calculated as the difference between the exercise price of the underlying options and the market price of our common stock as of December 31, 2010.

The following table summarizes information with respect to stock options and warrants outstanding as of December 31, 2010:

												Weighted
						Weighted						Average
				Number		Average		Weighted		Number		Exercise
				Outstanding		Remaining		Average		Exercisable		Price
Range of				As of		Contractual		Exercise		As of		As of
Exercise Prices				December 31,		Term		Price		December 31,		December 31,
				2010		(in years)				2010		2010
$	1.20	-	1.20		15,622		7.78		1.20		12,496	$	1.20
	2.34	-	2.34		290,097		7.63		2.34		155,284		2.34
	3.44	-	3.94		38,539		4.61		3.60		35,257		3.62
	4.20	-	4.20		155,703		6.37		4.20		120,006		4.20
	4.60	-	4.60		136,100		4.16		4.60		136,100		4.60
	4.63	-	5.62		33,350		6.15		4.97		33,350		4.97
	6.00	-	6.00		126,241		0.69		6.00		126,241		6.00
	6.11	-	18.11		100,919		3.96		10.76		99,669		10.70
	30.00	-	34.80		790		1.11		30.28		790		30.28
	37.08	-	37.08		230		2.93		37.08		230		37.08
$	1.20		$37.08		897,591		5.31	$	4.63		719,423	$	5.08

As of December 31, 2010, there was $336 of total unrecognized compensation cost related to outstanding options and warrants which the Company expects to recognize over a period of 1.63 years.

Restricted Stock Units

The following table summarizes the Company’s RSU activity for the three months ended December 31, 2010:

	Number of Shares			Weighted Avg. Grant Date Fair Value
Balance, September 30, 2010		19,917		$	0.49
Granted		565,181		$	0.49
Forfeited		(3,507	)	$	0.51
Vested		(16,410	)	$	0.51
Balance, December 31, 2010		565,181		$	0.52

Unvested restricted stock at December 31, 2010

As of December 31, 2010 there was $196 of total unrecognized compensation cost related to outstanding RSUs which the Company expects to recognize over a period of 3.85 years.

2. Inventories:

Inventories are stated at the lower of cost or market. Cost is computed using standard cost, which approximates actual cost on a first-in, first-out basis and includes material, labor and manufacturing overhead costs. Any excess and obsolete provision is only released if and when the related inventory is sold or scrapped. During the nine months ended December 31, 2010 and 2009, the Company sold or scrapped previously reserved inventory of $0 and $74, respectively. The inventory provision balance at December 31, 2010 and December 31, 2009 was $547 and $7,828, respectively. The inventory provision for the three month period ending December 31, 2009 was related to legacy products, which were sold in the prior fiscal year.

Net inventories for the periods presented consisted of:

	December 31, 2010		March 31, 2010
Raw materials	$	380	$	386
Work in progress		39		39
Finished goods and spares		777		796
	$	1,196	$	1,221

The Company periodically analyzes any systems that are in finished goods inventory to determine if they are suitable for current customer requirements. At the present time, the Company’s policy is that, if after approximately 18 months, it determines that a sale will not take place within the next twelve months and the system would be useable for customer demonstrations or training, it is transferred to fixed assets. Otherwise, it is expensed.

3. Product Warranty:

The Company provides warranties on all system sales based on the estimated cost of product warranties at the time revenue is recognized. The warranty obligation is affected by product failure rates, material usage rates, and the efficiency by which the product failure is corrected. Warranty activity for the three and nine months ended December 31, 2010 and 2009 is as follows:

	Warranty Activity for the						Warranty Activity for the
	Three Months Ended						Nine Months Ended
	December 31,						December 31,
	2010			2009			2010			2009
Balance at the beginning of the period	$	474		$	519		$	374		$	702
Additional warranty accruals for warranties issued during the period		80			320			385			562
Warranty expense during the period		(218	)		(445	)		(423	)		(870	)
Balance at the end of the period	$	336		$	394		$	336		$	394

Certain of the Company’s sales contracts include provisions under which customers would be indemnified by the Company in the event of, among other things, a third-party claim against the customer for intellectual property rights infringement related to the Company’s products. There are no limitations on the maximum potential future payments under these guarantees. The Company has accrued no amounts in relation to these provisions as no such claims have been made, and the Company believes it has valid, enforceable rights to the intellectual property embedded in its products.

4. Net Income Loss Per Common Share (EPS):

Basic EPS is computed by dividing net (loss) income available to common stockholders (numerator) by the weighted average number of common shares outstanding (denominator) for the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period. The computation of diluted EPS uses the average market prices during the period. All amounts in the following table are in thousands except per share data.

Basic net loss per common share is computed using the weighted-average number of shares of common stock outstanding.

The following table represents the calculation of basic and diluted net loss per common share (in thousands, except per share data):

	Three Months Ended						Nine Months Ended
	December 31,						December 31,
	2010			2009			2010			2009
Net loss applicable to common stockholders	$	(92	)	$	(8,779	)	$	(2,426	)	$	(13,075	)
Basic and diluted:
Weighted-average common shares outstanding		8,442			8,425			8,439			8,418
Weighted-average common shares used in diluted net (loss) income per common share		8,442			8,425			8,439			8,418
Basic net loss per common share	$	(0.01	)	$	(1.04	)	$	(0.29	)	$	(1.55	)
Diluted net loss per common share	$	(0.01	)	$	(1.04	)	$	(0.29	)	$	(1.55	)

Outstanding options and RSUs of 1,481,299 and 2,539,614 shares of common stock at a weighted-average exercise price per share of $3.01 and $8.82 on December 31, 2010 and 2009, respectively, were not included in the computation of diluted net (loss) income per common share for the nine month periods presented as a result of their anti-dilutive effect. Such securities could potentially dilute earnings per share in future periods.

5. Financial Instruments:

The carrying amount of the Company’s financial instruments, including cash and cash equivalents, accounts receivable and accounts payable, notes receivable, accrued expenses and other liabilities approximates fair value due to their relatively short maturity. The Company sells products in various global markets. As a result, the Company is exposed to changes in foreign currency exchange rates. The Company does not hold derivative financial instruments for speculative purposes. Foreign currency transaction gains and (losses) included in other income (expense), were $80 and $113 for the nine months ended December 31, 2010 and 2009, respectively. On December 31, 2010, the Company had no open foreign exchange contracts to sell Euros or any other foreign currencies. On December 31, 2010, the Company had 125,941 warrants outstanding with an exercise price of $6.00 expiring between June 2011 and September 2011. The Company recorded a non-cash gain of $3 and $53 in the quarter ending December 31, 2010 and December 31, 2009 related to these warrants.

6. Asset Acquisitions and Sales:

On September 16, 2008, the Company acquired certain assets from Alcatel Micro Machining Systems (“AMMS“) and Alcatel Lucent (together, the “Sellers”). With this acquisition, we entered the DRIE market. DRIE is a highly anisotropic etch process used to create deep, steep-sided holes and trenches in wafers, with aspect ratios of 20:1 or more. DRIE was developed for micro-electro-mechanical systems (“MEMS”), which require these features, but is also used to excavate trenches for high-density capacitors for DRAM and more recently for creating TSVs in advanced 3-D wafer level packaging technology. The acquisition was designed to enable us to pursue the high-growth markets in MEMS and certain segments of integrated semiconductor device manufacturing and packaging. Current end-markets include production of a variety of MEMS and power devices, memory stacking (flash and DRAM), logic, RF-SiP, and CMOS image sensors. The Company paid $1,000,000 in cash and $4,000,000 in shares of the Company’s common stock. The 1,044,386 shares of common stock issued by the Company was calculated by obtaining the quotient of (a) $4,000,000 divided by (b) the average of the closing sales prices of the Common Stock as reported on the Nasdaq Capital Market on the five (5) consecutive trading days immediately prior to (but excluding) the closing date.

In connection with this acquisition, the Company and Alcatel Lucent entered into an intellectual property agreement providing for the transfer of specified intellectual property rights to the Company, a trademark license agreement allowing for the limited use of the AMMS trademark by the Company, and a preferred supplier agreement pursuant to which the Company will purchase certain equipment from an affiliate of the Sellers. AMMS designated Mr. Gilbert Bellini to serve as a member of the Company’s board of directors. AMMS’ designation right terminates upon the later of (a) the termination or expiration of certain customer services related agreements, and (b) when AMMS beneficially owns less than 5% of the number of shares of Common Stock issued and outstanding (including the shares to be issued to the Sellers).

The purchase price was allocated as follows (in thousands):

Assets acquired:
Trademarks	$	428
Patents		2,648
Total Intangible Assets		3,076

Fixed Assets		24
Inventory		1,900
Total Tangible Assets		1,924

Total Acquired Assets	$	5,000

Beginning in the fiscal third quarter of 2009, following the acquisition of the DRIE product lines from AMMS, the Company experienced a sharp decline in revenues related to its legacy Etch and PVD products, a result of the overall collapse of the semiconductor capital equipment market and the global financial crisis. The management and the Board of Directors of the Company considered several alternatives for dealing with this decline in revenues, including the sale of assets which the Company could no longer support. On March 19, 2010, the Company and its wholly owned subsidiary, SFI, sold inventory, equipment, intellectual property and other assets related to the Company’s legacy Etch and PVD products to OEM Group Inc. (“OEM Group”), a company based in Phoenix, Arizona that specializes in “life cycle management” of legacy product lines for several semiconductor equipment companies. The sale included the product lines and associated spare parts and service business of the Company’s 900 and 6500 series plasma etch systems, along with the Endeavor and AMS PVD systems from SFI. In connection with the sale of the assets, OEM Group assumed the Company’s warranty liability for recently sold legacy Etch and PVD systems.

The Company and OEM Group entered into related agreements for the transfer and licensing of patents, trademarks and other intellectual property associated with the legacy Etch and PVD products. These included a Trademark Assignment Agreement for certain trademarks used in the legacy Etch and PVD Products, a royalty-free Trademark License Agreement allowing for the limited use of the Tegal trademark by the purchaser solely in connection with future sales of legacy Etch and PVD products and solely in combination with the trademarks transferred to purchaser, a Patent Assignment Agreement for the transfer of certain patents related to the Etch and PVD products, and a perpetual, irrevocable, non-exclusive, worldwide, fully-paid, royalty-free, Intellectual Property Cross License Agreement, pursuant to which the Company granted OEM Group a license to certain intellectual property owned by the Company for use in OEM Group’s manufacture and sale of the legacy Etch and PVD products, and OEM Group licensed back to the Company certain intellectual property for the Company’s continued use.

The consideration paid by OEM Group consisted of the following:

Cash in the amount of $250,000 paid at closing, which occurred on March 19, 2010;

An aggregate of $1,750,000 cash payable to the Company by four installment payments of $250,000, $500,000, $500,000 and $500,000 each on July 1, 2010, October 1, 2010, January 1, 2011 and April 1, 2011, respectively; and

A contingent payment in cash of up to $1,000,000 payable to the Company by April 15, 2011 based on the following percentage of applicable bookings of Etch and PVD products in excess of $6,000,000 received by the Company or OEM Group during the period beginning March 19, 2010 through March 31, 2011:

if applicable bookings are greater than or equal to $6,000,000 but less than $8,000,000, the contingent payment will be 5% of the applicable bookings in excess of $6,000,000;

if applicable bookings are greater than or equal to $8,000,000 but less than $10,000,000, the contingent payment will be $100,000 plus 10% of the applicable bookings in excess of $8,000,000;

if applicable bookings are greater than or equal to $10,000,000 but less than $12,000,000, the contingent payment will be $300,000 plus 15% of the applicable bookings in excess of $10,000,000; and

if applicable bookings are greater than or equal to $12,000,000, the contingent payment will be $600,000 plus 20% of the applicable bookings in excess of $12,000,000.

In no case will the contingent payment exceed $1,000,000.

The Company retained the DRIE products which it had acquired from AMMS, along with the Compact™ cluster platform and the NLD technology that it had developed over the past several years. However, the DRIE products and a small amount of associated spares and service revenue currently represent the sole source of the Company’s revenue. The DRIE markets were seriously impacted by the downturn in the semiconductor markets, and as those markets recover the Company is not in a position to make the needed investments to improve its competitive position. In addition, it is not clear that even with additional investment and significant reductions in operating expenses that DRIE sales alone will be enough to support the Company. As a result, the Company is seeking a strategic partner for its remaining business. The Company is also continuing to evaluate various other alternative strategies, including sale of its DRIE products, Compact™ platform and NLD technology, the transition to a new business model, a sale of all or substantially all of its assets, or its voluntary liquidation. Please see “Notes to Condensed Consolidated Financial Statements – 9. Subsequent Event – Update to Reorganization/Strategic Alternatives.”

7. Geographical Information:

The Company operates in one segment for the manufacture, marketing and servicing of integrated circuit fabrication equipment. In accordance with SFAS No. 131 (Topic 280), Disclosures About Segments of an Enterprise and Related Information, (“SFAS 131”) (Topic 280) the Company’s chief operating decision-maker has been identified as the President and Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing performance for the entire company.

For geographical reporting, revenues are attributed to the geographic location in which the customers’ facilities are located. Long-lived assets consist of property, plant and equipment and are attributed to the geographic location in which they are located. Net sales and long-lived assets by geographic region were as follows:

	Revenue for the				Revenue for the
	Three Months Ended				Nine Months Ended
	December 31,				December 31,
	2010		2009		2010		2009
Sales to customers located in:
United States	$	108	$	1,777	$	497	$	4,929
Asia		979		1,751		983		2,146
Germany		—		1,153		11		1,240
France		125		138		954		319
Europe, excluding Germany and France		133		253		2,402		638
Total sales	$	1,345	$	5,072	$	4,847	$	9,272

	December 31
	2010		2009
Long-lived assets at period-end:
United States	$	137	$	1,114
Europe		8		1,698
Total Long-lived assets	$	145	$	2,812

8. Recent Accounting Pronouncements:

In January 2010, FASB issued ASU No. 2010-06, Fair Value Measurements and Disclosures (Topic 820): Improving Disclosures about Fair Value Measurements. ASU No. 2010-06 amends ASC 820 and clarifies and provides additional disclosure requirements on the transfers of assets and liabilities between Level 1 (quoted prices in active market for identical assets or liabilities) and Level 2 (significant other observable inputs) of the fair value measurement hierarchy, including the reasons for and the timing of the transfers. Additionally, the guidance requires a roll forward of activities on purchases, sales, issuance, and settlements of the assets and liabilities measured using significant unobservable inputs (Level 3 fair value measurements). Adoption of this new guidance will not have a material impact on our financial statements.

9. Subsequent Event – Update to Reorganization/Strategic Alternatives:

Entry Into a Material Definitive Agreement.

On February 9, 2011, Tegal Corporation, a Delaware corporation (the “Company”), and SPP Process Technology Systems Limited, a company incorporated and registered in England and Wales (together with its subsidiary designees, “Purchaser”), entered into an Asset Purchase Agreement (the “Purchase Agreement”) pursuant to which the Company sold to Purchaser (the “Disposition”) all of the shares of Tegal France, SAS, the Company’s wholly-owned subsidiary (the “Tegal France Shares”), and product lines and certain equipment, intellectual property and other assets relating to the Company’s Deep Reactive Ion Etch plasma etch systems and certain related technology (together with the Tegal France Shares, the “Purchased Assets”). The Purchaser also assumed existing customer contracts, including all installation and warranty obligations of existing customers, and other liabilities arising after the closing of the Disposition (the “Assumed Liabilities”).

In connection with the Disposition, the Company and the Purchaser entered into related agreements for the transfer and licensing of patents, trademarks and other intellectual property associated with the Included Businesses, including a royalty-free Trademark License Agreement allowing for the limited use of the Tegal trademark by the Purchaser solely in connection with future sales related to the Included Businesses and solely in combination with the trademarks transferred to the Purchaser, as well as written assignments to the Purchaser of all rights in the patents and trademarks that are part of the Disposition.

The Disposition closed immediately after execution of the Purchase Agreement. The consideration paid by the Purchaser for the Disposition totaled approximately $2.1 million, comprised of approximately $0.5 million of Assumed Liabilities and $1.6 million in cash, of which $200,000 in cash will be held in escrow for one year after the closing of the Disposition to satisfy any indemnification obligations of the Company under the Purchase Agreement.

The Company will file a Form 8-K by February 15, 2011, giving notice of the above material definitive agreement.

On January 14, 2011, Tegal Corporation (the “Company”), se2quel Partners LLC, a California limited liability company (“se2quel Partners”), and sequel Power LLC, a newly formed Delaware limited liability company (“sequel Power”), entered into a Formation and Contribution Agreement (the “Contribution Agreement”). sequel Power is focused on the promotion of solar power plant development projects worldwide, the development of self-sustaining businesses from such projects, including but not limited to activities relating to and supporting, developing, building and operating solar photovoltaic fabrication facilities and solar farms, and the consideration of other non-photovoltaic renewable energy projects. se2quel Partners is owned by Ferdinand Seemann, who previously served as an independent member of the Company’s Board of Directors. Pursuant to the Contribution Agreement, the Company contributed $2 million in cash to sequel Power in exchange for an approximate 25% ownership interest and a 51% voting interest in sequel Power. In addition, the Company issued warrants (“Warrants”) to se2quel Partners and se2quel Management GmbH, a German limited liability company, to purchase an aggregate of 928,884 shares of the Company’s common stock at an exercise price of $0.63 per share. The Warrants are exercisable for a period of four years. The fair market value of the warrants issued is $230,000 using the Black Scholes valuation model with the valuation assumptions of: Stock Price: $0.53, Exercise Price: $0.53, Maturity: 4 Years, Risk Free Interest Rate: 0.13%, and Volatility: 61%. The company is currently evaluating the proper recording of this transaction under Topic 810 Consolidation.

The Company filed a Form 8-K on January 21, 2011, giving notice of the above material definitive agreement.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations – (Amounts in thousands)

Special Note Regarding Forward Looking Statements

Information contained or incorporated by reference in this report contains forward-looking statements. These forward-looking statements are based on current expectations and beliefs and involve numerous risks and uncertainties that could cause actual results to differ materially from expectations. These forward-looking statements should not be relied upon as predictions of future events as we cannot assure you that the events or circumstances reflected in these statements will be achieved or will occur. You can identify forward-looking statements by the use of forward-looking terminology such as “may,“ “will,“ “expect,“ “anticipate,“ “estimate“ or “continue“ or the negative thereof or other variations thereon or comparable terminology which constitutes projected financial information. These forward-looking statements are subject to risks, uncertainties and assumptions about Tegal Corporation including, but not limited to, industry conditions, economic conditions, acceptance of new technologies and market acceptance of Tegal Corporation’s products and service. For a discussion of the factors that could cause actual results to differ materially from the forward-looking statements, see “Part II, Item 1A.—Risk Factors“ and the “Liquidity and Capital Resources“ section set forth in this section and such other risks and uncertainties as set forth below in this report or detailed in our other SEC reports and filings. We assume no obligation to update forward-looking statements.

Tegal Corporation, a Delaware corporation (“Tegal” or the “Company”), designs, manufactures, markets and services specialized plasma etch systems used primarily in the production of micro-electrical mechanical systems (“MEMS”) devices, such as sensors and accelerometers as well as power devices. The Company’s Deep Reactive Ion Etch (“DRIE”) systems are also employed in certain sophisticated manufacturing techniques, such as 3-D interconnect structures formed by intricate silicon etching, also known as Deep Silicon Etch (“DSE”) for so-called Through Silicon Vias (“TSVs”). Prior to its fiscal year 2011, Tegal also sold systems for the etching and deposition of materials found in other devices, such as integrated circuits (“ICs”) and optoelectronic devices found in products like smart phones, networking gear, solid-state lighting, and digital imaging.

In the recent past, our business objective has been to utilize the technologies that we have developed internally or acquired externally in order to increase our market share in process equipment for MEMS and power device fabrication, advanced 3-D packaging, and certain areas of semiconductor manufacturing. In September 2008, we acquired the products lines of AMMS and the related intellectual property of Alcatel, in order to pursue more fully the smaller, but higher-growth markets of MEMS and 3-D packaging. Our acquisition of these products served two purposes: (i) to increase revenue, and (ii) to enable us to focus our various technologies on specific applications that served the common markets of MEMS and 3-D device manufacturing and packaging.

Beginning in the fiscal third quarter of 2009, following the acquisition of the DRIE product lines from AMMS, the Company experienced a sharp decline in revenues related to its legacy Etch and PVD products, a result of the collapse of the semiconductor capital equipment market and the global financial crisis. The management and the Board of Directors of the Company considered several alternatives for dealing with this decline in revenues, including the sale of assets which the Company could no longer support. On March 19, 2010, the Company and its wholly owned subsidiary, SFI, sold inventory, equipment, intellectual property and other assets related to the Company’s legacy Etch and PVD products to OEM Group Inc. (“OEM Group”), a company based in Phoenix, Arizona that specializes in “life cycle management“ of legacy product lines for several semiconductor equipment companies. The sale included the product lines and associated spare parts and service business of the Company’s 900 and 6500 series plasma etch systems, along with the Endeavor and AMS PVD systems from SFI. In connection with the sale of the assets, OEM Group assumed the Company’s warranty liability for recently sold legacy Etch and PVD systems.

The Company retained the DRIE products which it had acquired from AMMS, along with the Compact™ cluster platform and the NLD technology that it had developed over the past several years. However, the DRIE products and a small amount of associated spares and service revenue currently represent the sole source of the Company’s revenue. The DRIE markets were seriously impacted by the downturn in the semiconductor markets and and as those markets recover the Company is not in a position to make the needed investments to improve its competitive position. In addition, it is not clear that even with additional investment and significant reductions in operating expenses that DRIE sales alone will be enough to support the Company. As a result, the Company is seeking a strategic partner for its remaining business. The Company is also continuing to evaluate various other alternative strategies, including sale of its DRIE products, Compact™ platform and NLD technology, the transition to a new business model, a sale of all or substantially all of our assets, or the liquidation or dissolution of the Company, including through a bankruptcy proceeding. We cannot assure you that we will be successful in pursuing any of these strategic alternatives. As we pursue various strategic alternatives and determine that some are more or less likely than others, the consequences of such determinations will be reflected in our financial statements as required by generally accepted accounting principles (“GAAP”) or the Financial Accounting Standards Board (“FASB”). Please see “Notes to Condensed Consolidated Financial Statements – 9. Subsequent Event – Update to Reorganization/Strategic Alternatives.”

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The consolidated financial statements have been prepared using the going concern basis, which assumes that we will be able to realize our assets and discharge our liabilities in the normal course of business for the foreseeable future. However, it is not possible to predict when our business and results of operations will improve in light of the current economic downturn that continues to dramatically affect our industry. Therefore, the realization of assets and discharge of liabilities are each subject to significant uncertainty. Accordingly, substantial doubt exists as to whether we will be able to continue as a going concern. If the going concern basis is not appropriate in future filings, adjustments will be necessary to the carrying amounts and/or classification of assets and liabilities in our consolidated financial statements included in such filings.

The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to revenue recognition, bad debts, sales returns allowance, inventory, intangible and long lived assets, warranty obligations, restructure expenses, deferred taxes and freight charged to customers. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

In consideration of these circumstances, we continue to evaluate strategic alternatives for the Company, which may include a merger with or into another company, a transition to a new business model, a sale of all or substantially all of our assets or the liquidation or dissolution of the Company, including through a bankruptcy proceeding. Please see “Notes to Condensed Consolidated Financial Statements – 9. Subsequent Event – Update to Reorganization/Strategic Alternatives.” We cannot assure you that we will be successful in pursuing any of these strategic alternatives. As we pursue various strategic alternatives and determine that some are more or less likely than others, the consequences of such determinations will be reflected in our financial statements as required by GAAP or FASB.

We believe the following critical accounting policies are the most significant to the presentation of our consolidated financial statements:

Revenue Recognition

Each sale of our equipment is evaluated on an individual basis in regard to revenue recognition. We have integrated in our evaluation the related interpretative guidance included in Topic 13 of the codification of staff accounting bulletins, and recognize the role of the consensus on Emerging Issues Task Force Issue No. 00-21, Accounting for Revenue Arrangements with Multiple Deliverables (“EITF Issue 00-21“) (Topic 605). We first refer to EITF Issue 00-21 (Topic 605) in order to determine if there is more than one unit of accounting and then we refer to Staff Accounting Bulletin (“SAB“) 104 (Topic 605) for revenue recognition topics for the unit of accounting. We recognize revenue when persuasive evidence of an arrangement exists, the seller’s price is fixed or determinable and collectability is reasonably assured.

For products produced according to our published specifications, where no installation is required or installation is deemed perfunctory and no substantive customer acceptance provisions exist, revenue is recognized when title passes to the customer, generally upon shipment. Installation is not deemed to be essential to the functionality of the equipment since installation does not involve significant changes to the features or capabilities of the equipment or building complex interfaces and connections. In addition, the equipment could be installed by the customer or other vendors and generally the cost of installation approximates only 1% of the sales value of the related equipment.

For products produced according to a particular customer’s specifications, revenue is recognized when the product has been tested and it has been demonstrated that it meets the customer’s specifications and title passes to the customer. The amount of revenue recorded is reduced by the amount (generally 10%), which is not payable by the customer until installation is completed and final customer acceptance is achieved.

For new products, new applications of existing products, or for products with substantive customer acceptance provisions where performance cannot be fully assessed prior to meeting customer specifications at the customer site, 100% of revenue is recognized upon completion of installation and receipt of final customer acceptance. Since title to goods generally passes to the customer upon shipment and 90% of the contract amount becomes payable at that time, inventory is relieved and accounts receivable is recorded for the entire contract amount. The Company relieves the entire amount from inventory at the time of sale, and the related deferred revenue liability is recognized upon installation and customer acceptance. The revenue on these transactions is deferred and recorded as deferred revenue. We reserve for warranty costs at the time the related revenue is recognized.

The Company’s return policy is for spare parts and components only. A right of return does not exist for systems. Customers are allowed to return spare parts if they are defective upon receipt. The potential returns are offset against gross revenue on a monthly basis. Management reviews outstanding requests for returns on a quarterly basis to determine that the reserves are adequate.

Accounting for Stock-Based Compensation

The Company has adopted several stock plans that provide for issuance of equity instruments to our employees and non-employee directors. Our plans include incentive and non-statutory stock options and restricted stock awards. These equity awards generally vest ratably over a four-year period on the anniversary date of the grant, and stock options expire ten years after the grant date. Certain restricted stock awards may vest on the achievement of specific performance targets. The Company also has an Employee Stock Purchase Plan (“ESPP”) that allows qualified employees to purchase Tegal shares at 85% of the fair market value on specified dates. The stock-based compensation for our ESPP was determined using the Black-Scholes option pricing model and the provisions of SFAS No. 123 (revised 2004), Share Based Payment (“SFAS 123R”) (Topic 718).

Accounts Receivable – Allowance for Sales Returns and Doubtful Accounts

The Company maintains an allowance for doubtful accounts receivable for estimated losses resulting from the inability of the Company’s customers to make required payments. If the financial condition of the Company’s customers were to deteriorate, or even a single customer was otherwise unable to make payments, additional allowances may be required. As of December 31, 2010, two customers accounted for approximately 73% of the accounts receivable balance. As of December 31, 2009, three customers accounted for approximately 49% of the accounts receivable balance.

Inventories

Inventories are stated at the lower of cost or market. Cost is computed using standard cost, which approximates actual cost on a first-in, first-out basis and includes material, labor and manufacturing overhead costs. Any excess and obsolete provision is only released if and when the related inventory is sold or scrapped. During the nine months ended December 31, 2010 and 2009, the Company sold or scrapped previously reserved inventory of $0 and $74, respectively. The inventory provision balance at December 31, 2010 and December 31, 2009 was $547 and $7,828, respectively. The inventory provision for the period ending December 31, 2009 was related to legacy products, which were sold in the prior fiscal year.

The Company periodically analyzes any systems that are in finished goods inventory to determine if they are suitable for current customer requirements. At the present time, the Company’s policy is that, if after approximately 18 months, it determines that a sale will not take place within the next 12 months and the system would be useable for customer demonstrations or training, it is transferred to fixed assets. Otherwise, it is expensed.

The carrying value of systems used for demonstrations or training is determined by assessing the cost of the components that are suitable for sale. Any parts that may be rendered unsellable as a result of such use are removed from the system and are not included in finished goods inventory. The remaining saleable parts are valued at the lower of cost or market, representing the system’s net realizable value. The depreciation period for systems that are transferred to fixed assets is determined based on the age of the system and its remaining useful life (typically five to eight years).

Impairment of Long-Lived Assets

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable as well as at fiscal year end. If undiscounted expected future cash flows are less than the carrying value of the assets, an impairment loss is recognized based on the excess of the carrying amount over the fair value of the assets. During the quarter ended December 31, 2010, we reviewed our long-lived assets for indicators of impairment in accordance with SFAS No. 144, (Topic 360). No impairment charges were recorded for long-lived assets for the nine months ended December 31, 2010. For the fiscal year ended March 31, 2010, the Company recorded a $1,064 impairment charge for intangible assets and a $1,558 impairment charge for its fixed assets.

Warranty Obligations

We provide for the estimated cost of our product warranties at the time revenue is recognized. Our warranty obligation is affected by product failure rates, material usage rates and the efficiency by which the product failure is corrected. The warranty reserve is based on historical cost data related to warranty. Should actual product failure rates, material usage rates and labor efficiencies differ from our estimates, revisions to the estimated warranty liability may be required. Actual warranty expense is typically low in the period immediately following installation.

Deferred Taxes

We record a valuation allowance to reduce our deferred tax assets to the amount that is more likely than not to be realized. Based on the uncertainty of future taxable income, we have fully reserved our deferred tax assets. In the event we were to determine that we would be able to realize our deferred tax assets in the future, an adjustment to the deferred tax asset would increase income in the period such determination was made.

Results of Operations

The following table sets forth certain financial data for the three and nine months ended December 31, 2010 and 2009 as a percentage of revenue:

	Three Months Ended						Nine Months Ended
	December 31,						December 31,
	2010			2009			2010			2009

Revenue		100.0	%		100.0	%		100.0	%		100.0	%
Cost of revenue		31.2	%		209.2	%		60.3	%		149.6	%
Gross profit/(loss)		68.8	%		(109.2	)%		39.7	%		(49.6	)%
Operating expenses:
Research and development		54.5	%		29.6	%		47.4	%		42.2	%
Sales and marketing		15.6	%		10.6	%		10.7	%		20.6	%
General and administrative		41.2	%		18.9	%		54.3	%		31.6	%
Total operating expenses		111.3	%		59.1	%		112.4	%		94.4	%
Operating loss		(42.5	)%		(168.3	)%		(72.7	)%		(144.0	)%
Other income (expense), net		35.7	%		(4.8	)%		22.8	%		2.4	%
Loss before income tax benefit		(6.8	)%		(173.1	)%		(49.9	)%		(141.6	)%
Tax Expense		—	%		—	%		0.1	%		(0.5	)%
Net loss		(6.8	)%		(173.1	)%		(50.0	)%		(141.1	)%

The following table sets forth certain financial items for the three and nine months ended December 31, 2010 and 2009:

	Three Months Ended						Nine Months Ended
	December 31,						December 31,
	2010			2009			2010			2009

Revenue	$	1,345		$	5,072			4,847		$	9,272
Inventory Provision		-			7,828			-			7,828
Cost of revenue		420			2,780			2,922			6,039
Gross profit/(loss)		925			(5,536	)		1,925			(4,595	)
Operating expenses:
Research and development expenses		733			1,503			2,298			3,913
Sales and marketing expenses		210			539			518			1,914
General and administrative expenses		554			957			2,631			2,930
Total operating expenses		1,497			2,999			5,447			8,757
Operating loss		(572	)		(8,535	)		(3,522	)		(13,352	)
Other income (expense), net		480			(244	)		1,103			227
Loss before income tax benefit		(92	)		(8,779	)		(2,419	)		(13,125	)
Income tax expense (benefit)		—			—			7			(50	)
Net loss	$	(92	)	$	(8,779	)	$	(2,426	)	$	(13,075	)

Net loss per share:
Basic	$	(0.01	)	$	(1.04	)	$	(0.29	)	$	(1.55	)
Diluted	$	(0.01	)	$	(1.04	)	$	(0.29	)	$	(1.55	)
Weighted average shares used in per share computation:
Basic		8,442			8,425			8,439			8,418
Diluted		8,442			8,425			8,439			8,418

Revenue

Our revenue is derived from sales of new and refurbished systems, spare parts and non-warranty service. Revenue of $1,345 for the three months ended December 31, 2010 decreased by $3,727 from revenue for the three months ended December 31, 2009. The revenue decrease was due principally to the sale of our legacy Etch and PVD assets to OEM Group, as well as the number and mix of systems sold. For the three month period ended December 31, 2010, we sold only one new DRIE system, as well as spare parts and service sales compared to the four new DRIE systems sold in the same period last year, as well as spare parts and service sales, including sales derived from our legacy assets.

Revenue of $4,847 for the nine months ended December 31, 2010 decreased from revenue for the nine months ended December 31, 2009 of $9,272. The $4,425 decrease in revenue for the nine months ended December 31, 2010 was mainly from a narrowed product mix due to the sale of legacy Etch and PVD assets to OEM Group, as well as the number and mix of systems sold. For the nine months ended December 31, 2010, we sold four new DRIE systems, as well as spare parts and service sales, compared to the sale of two SMT systems and five new DRIE systems, as well as spare parts and service sales, including sales derived from our legacy assets, in the same period last year.

As a percentage of total revenue for the three months ended December 31, 2010 international sales were approximately 92%. As a percentage of total revenue for the three months ended December 31, 2009 international sales were approximately 65%. The increase in international sales as a percentage of revenue can be attributed to the number and mix of systems being sold in the third quarter of fiscal year 2011 to international markets. As a percentage of total revenue for the nine months ended December 31, 2010 international sales were approximately 90%. As a percentage of total revenue for the nine months ended December 31, 2009 international sales were approximately 47%. The Company typically sells more systems in international markets. We believe that international sales will continue to represent a significant portion of our future revenue.

Gross Profit

Gross profit of $925 for the three months ended December 31, 2010 increased by $6,461 from gross profit (loss) of ($5,536) for the three months ended December 31, 2009. Gross profit of $1,925 for the nine months ended December 31, 2010 increased by $6,520 from gross profit (loss) of ($4,595) for the nine months ended December 31, 2009.

Our gross margin for the three months ended December 31, 2010 was 69% compared to (109%) for the same period last year. Our gross margin for the nine months ended December 31, 2010 was 40% compared to (50%) for the same period last year. Gross margins for our DRIE series systems are typically lower than the margins from previous product lines sold by Tegal.

Our gross margin as a percentage of revenue has been, and will continue to be, affected by a variety of factors, including the mix and average selling prices of systems sold and the costs to manufacture, service and support new product introductions and enhancements. Gross margins for our DRIE systems are generally lower than we have experienced in the past from the sale of our legacy Etch and PVD products, which were sold to OEM Group in March 2010. The principal reasons for the lower margins are: (i) price pressure resulting from customers’ historic expectations for the equipment for MEMS productions versus semiconductors; (ii) extreme competition from competitors seeking to gain market share; and (iii) our current manufacturing model, which includes substantial outsourcing of system assembly.

The increase in the gross profit was primarily attributable to the excess inventory provision recognized in the third quarter of the prior fiscal year. As part of the valuation testing mandated by SFAS No. 144 (Topic 360), and in connection with the evaluation of strategic alternatives available, the Company reviewed the carrying value of all its inventory. As a result of its review, for the three months ended December 31, 2009, the Company recorded an excess inventory provision of $7,828. The gross margin is also affected by the increased costs associated with the outsourcing of the manufacturing of the DRIE systems. With the sale of the legacy etch and PVD assets to OEM Group, the Company’s fixed manufacturing and related expenses decreased significantly, offsetting the increased costs associated with the outsourced manufacturing of the DRIE systems.

During the quarter ended December 31, 2010, we focused our efforts on the continued operation of the Company with the DRIE product lines acquired from AMMS as our main business. Due to limited resources, we discontinued our development efforts in NLD, while offering these assets for sale to third-parties. Since the DRIE markets were also seriously impacted by the downturn in the semiconductor markets, the lack of available capital for new product development globally, and our deteriorating competitive position, it was unclear that DRIE sales alone would be enough to continue supporting the Company, even with significant reductions in the Company’s operating expenses resulting from the sale of the legacy Etch and PVD business, as well as a continuation of cost containment measures. Accordingly, while we were continuing to focus our efforts on the operation of the DRIE business, we were also seeking and evaluating strategic alternatives, including the continued operation of the Company as a stand-alone business with a different business plan, a merger with or into another company, a transition to a new business model, a sale of all or substantially all of our assets, and the liquidation or dissolution of the Company, including through a voluntary dissolution or a bankruptcy proceeding. Please see “Notes to Condensed Consolidated Financial Statements – 9. Subsequent Event – Update to Reorganization/Strategic Alternatives.” We cannot assure you that we will be successful in pursuing any of these strategic alternatives.

Research and Development

Research and development (“R&D“) expenses consist primarily of salaries, prototype material and other costs associated with our ongoing systems and process technology development, applications and field process support efforts for our DRIE product line. The spending decrease of $770 and $1,615 for the three and nine months ended December 31, 2010, respectively, compared to the three and nine months ended December 31, 2009 resulted primarily from a decrease in headcount, payroll, consulting expense, DRIE amortization and depreciation expense and legal fees for patent maintenance. These decreases were partially offset by increased spending on our R&D operations conducted by our subsidiary, Tegal France.

Sales and Marketing

Sales and marketing expenses consist primarily of salaries, commissions, trade show promotion and travel and living expenses associated with those functions. The decrease in sales and marketing spending of $329 and $1,396 for the three and nine months ended December 31, 2010, respectively, as compared to the same period in 2009 was primarily due to the decrease of employee costs.

General and Administrative

General and administrative expenses consist of salaries, legal, accounting and related administrative services and expenses associated with general management, finance, information systems, human resources and investor relations activities. The decrease of $403 for the three months ended December 31, 2010 as compared to the three months ended December 31, 2009 was due primarily to decreases in stock related compensation expense. The decrease of $299 for the nine months ended December 31, 2010 as compared to the nine months ended December 31, 2009 was due primarily to decreases in stock related compensation expense, legal expenses and consulting costs, offset by bonuses for key employees.

Other Income (expense), net

Other income, net, consists of interest income, other income, gains and losses on foreign exchange, reimbursements for expenses from the French government for research and development and gain and losses on the disposal of fixed assets. For the three months ended December 31, 2010 compared to the three months ended December 31, 2009, other income, net increased by $724, primarily due to a refund in the amount of $458 from the French government and changes in foreign exchange rates. For the nine months ended December 31, 2010 compared to the nine months ended December 31, 2009, other income, net increased by $876, primarily due to the refund from the French government in the amount of $627 and the $338 change in fair value of the common stock warrant liability pursuant to EITF 07-05 (Topic 815), offset by the changes in foreign exchange rates.

Contractual Obligation

The following summarizes our contractual obligations at December 31, 2010, and the effect such obligations are expected to have on our liquidity and cash flows in future periods (in thousands).

Contractual obligations:			Less than						After
	Total		1 Year		1-3 Years		3-5 Years		5 Years
Non-cancelable operating lease obligations	$	180	$	106	$	74	$	-	$	-
Total contractual cash obligations	$	180	$	106	$	74	$	-	$	-

The Company’s lease for the Petaluma facility expired on September 30, 2010. The Company entered into 2 separate office leases in Petaluma for a total of approx 4,000 square feet. These offices house the personnel associated with the DRIE operations and the general and administrative personnel.

Certain of our sales contracts include provisions under which customers would be indemnified by us in the event of, among other things, a third party claim against the customer for intellectual property rights infringement related to our products. There are no limitations on the maximum potential future payments under these guarantees. We have accrued no amounts in relation to these provisions as no such claims have been made, and we believe we have valid, enforceable rights to the intellectual property embedded in its products.

Liquidity and Capital Resources

For the nine months ended December 31, 2010, we financed our operations from existing cash on hand. In fiscal year ended March 31, 2010, we financed our operations through the use of existing cash balances. The primary significant changes in our cash flow statement for the nine months ended December 31, 2010 were decreases in accounts receivable and prepaid expenses offset by our net loss of ($2,426), and the decrease in accounts payable. Net cash used in operating activities during the nine months ended December 31, 2009 was ($3,827), due primarily to the net loss of $13,075 and the increase in accounts receivable offset by decreases in inventory and increased depreciation and amortization expense.

The consolidated financial statements contemplate the realization of assets and the satisfaction of liabilities in the normal course of business for the foreseeable future. We incurred net losses of ($2,426) and ($13,075) for the nine months ended December 31, 2010 and 2009, respectively. We generated (used) cash flows from operations of $314 and ($3,827) for the nine months ended December 31, 2010 and 2009, respectively. Although we believe that our existing cash balances, combined with continued cost containment, will be adequate to fund operations through fiscal year 2011, we believe there is substantial doubt as to our ability to continue as a going concern if there is not significant improvement in our competitive position and sales in the MEMS and semiconductor capital equipment sectors. The long-term viability of our operations is dependent upon our ability to generate sufficient cash to support our operating needs, fulfill business objectives and fund continued investment in technology and product development without incurring substantial indebtedness that will hinder our ability to compete, adapt to market changes and grow our business in the future. More specifically, our business is dependent upon the sales of our capital equipment, and projected sales may not materialize and unforeseen costs may be incurred. If the projected sales do not materialize, we would need to reduce expenses further and/or raise additional capital which may include capital raises through the issuance of debt or equity securities in order to continue our business. If additional funds are raised through the issuance of preferred stock or debt, these securities could have rights, privileges or preferences senior to those of our common stock, and debt covenants could impose restrictions on our operations. Moreover, such financing may not be available to us on acceptable terms, if at all. Failure to raise any needed funds would materially adversely affect us. Therefore, the realization of assets and discharge of liabilities are each subject to significant uncertainty. Accordingly, substantial doubt exists as to whether we will be able to continue as a going concern. If the going concern basis is not appropriate in future filings, adjustments will be necessary to the carrying amounts and/or classification of assets and liabilities in our consolidated financial statements included in such filings as the consolidated financial statements have been prepared using the going concern basis, which assumes that we will be able to realize our assets and discharge our liabilities in the normal course of business for the foreseeable future.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Foreign Currency Exchange Risk

At December 31, 2010 and 2009, all of the Company’s investments were classified as cash equivalents in the consolidated balance sheets. The investment portfolio at December 31, 2010 and 2009 was comprised of money market funds. Our exposure to foreign currency fluctuations is primarily related to purchases in Europe and Japan, which are denominated in the Euro and Yen. Foreign currency transaction gains and (losses) included in other income (expense), net were $24 and ($180) for the three months ended December 31, 2010 and 2009, respectively. For the nine months ended December 31, 2010 and December 31, 2009, the Company recorded transaction gains included in other income (expense), net of $80 and $113. Changes in the exchange rate between the Euro and the U.S. dollar could adversely affect our operating results. Exposure to foreign currency exchange rate risk may increase over time as our business evolves and our products continue to be sold into international markets. Periodically, the Company enters into foreign exchange contracts to sell Euros, which are used to hedge a sales transaction in which costs are denominated in U.S. dollars and the related revenue is generated in Euros. As of December 31, 2010, there were no outstanding foreign exchange contracts.

Interest Rate Risk

We are only marginally exposed to interest rate risk through interest earned on money market accounts. Interest rates that may affect these items in the future will depend on market conditions and may differ from the rates we have experienced in the past. We do not hold or issue derivatives, commodity instruments or other financial instruments for trading purposes.

Item 4. Controls and Procedures

Disclosure Controls and Internal Controls for Financial Reporting

Disclosure controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act such as this Quarterly Report on Form 10-Q, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Internal controls for financial reporting are procedures which are designed with the objective of providing reasonable assurance that our transactions are properly authorized, our assets are safeguarded against unauthorized or improper use and our transactions are properly recorded and reported, all to permit the preparation of our financial statements in conformity with U.S. GAAP.

Evaluation of Disclosure Controls and Procedures

As of the period covered by this quarterly report, management performed, with the participation of our Chief Executive Officer and Chief Financial Officer, an evaluation of the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) and 15d-15(e) of the Exchange Act. Our disclosure controls and procedures are designed to ensure that information required to be disclosed in the report we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures. Based on the evaluation, our Chief Executive Officer and Chief Financial Officer concluded that as of December 31, 2010, such disclosure controls and procedures were effective.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended December 31, 2010 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II — OTHER INFORMATION

Item 1A. Risk Factors

We wish to caution you that there are risks and uncertainties that could affect our business. A description of the risk factors associated with our business that you should consider when evaluating our business is included under “Risk Factors” contained in Item 1A. of our Annual Report on Form 10-K for the year ended March 31, 2010. In addition to those factors and to other information in this Form 10-Q, the following updates to the risk factors should be considered carefully when evaluating Tegal or our business.

We have incurred operating losses and may not be profitable in the future. Our plans to maintain and increase liquidity may not be successful.

We had net income (loss) of ($18,469), ($7,902), and $18,104 for the years ended March 31, 2010, 2009, and 2008, respectively. We used cash flows from operations of ($4,887), ($5,541), and ($5,057) in these respective years. For the three months ended December 31, 2010 and 2009, we had a net losses of ($92) and ($8,779), respectively. For the nine months ended December 31, 2010 and 2009, we had a net losses of ($2,426) and ($13,075), respectively. Although we believe that our existing cash balances, combined with continued cost containment will be adequate to fund operations through fiscal year 2011, we believe there is substantial doubt as to our ability to continue as a going concern if there is not significant improvement in our competitive position and sales in the MEMS and semiconductor capital equipment sectors. The long-term viability of our operations is dependent upon our ability to generate sufficient cash to support our operating needs, fulfill business objectives and fund continued investment in technology and product development without incurring substantial indebtedness that will hinder our ability to compete, adapt to market changes and grow our business in the future. More specifically, our current results are dependent upon the sales of our capital equipment, and projected sales may not materialize and unforeseen costs may be incurred. If the projected sales do not materialize, we would need to reduce expenses further and/or raise additional capital which may include capital raises through the issuance of debt or equity securities in order to continue our business. If additional funds are raised through the issuance of preferred stock or debt, these securities could have rights, privileges or preferences senior to those of our common stock, and debt covenants could impose restrictions on our operations. Moreover, such financing may not be available to us on acceptable terms, if at all. Failure to raise any needed funds would materially adversely affect us.

In consideration of these circumstances, we have engaged Cowen & Co., LLC to assist us in evaluating strategic alternatives for the Company, which may include a merger with or into another company, a sale of all or substantially all of our assets, the sale of our DRIE and other assets, and the liquidation or dissolution of the company, including through a bankruptcy proceeding. We cannot assure you that we will be successful in pursuing any of these strategic alternatives. If we were to liquidate or dissolve the company through or outside of a bankruptcy proceeding, you could lose all of your investment in Tegal common stock.

Item 6. Exhibits

	Exhibit
	Number		Description

	31.1		Certifications of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
	31.2		Certifications of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
	32		Certifications of the Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	TEGAL CORPORATION (Registrant)

	/s/ CHRISTINE T. HERGENROTHER
	Christine T. Hergenrother Chief Financial Officer

Date: February 14, 2011

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

Rennova Health (RNVA) 10-Q2010 Q4 Quarterly report

Content analysis